当前位置 >>  首页 >> 科学研究 >> 科研成果 >> 论文情况

论文情况

论文题目 作者 刊物名称 发表年
A survey of Prototheca bovis infection in dairy farms of the Hubei province, China Li J, Chen X, Jin E, Wang G, Wu L, Shao Z, Wan P, Hu C, Li J, Chen J, Ding M. J Vet Med Sci. 2021
Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients Chen X, Zhou J, Chen C, Hou B, Ali A, Li F, Hua Z, Wu Y, Yang Q, Chen M, Zhang R, Huang Q, Ding J, Zhang XE, Men D. Virol Sin. 2021
Passive cancer targeting with a viral nanoparticle depends on the stage of tumorigenesis Zhang J, Zhang W, Yang M, Zhu W, Li M, Liang A, Zhang H, Fang T, Zhang XE, Li F. Nanoscale 2021
Visualization and Analysis of Gene Expression in Stanford Type A Aortic Dissection Tissue Section by Spatial Transcriptomics Li YH, Cao Y, Liu F, Zhao Q, Adi D, Huo Q, Liu Z, Luo JY, Fang BB, Tian T, Li XM, Liu D, Yang YN. Front Genet. 2021
Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection Teng Y, Xu Z, Zhao K, Zhong Y, Wang J, Zhao L, Zheng Z, Hou W, Zhu C, Chen X, Protzer U, Li Y, Xia Y. J Hepatol. 2021
Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication Zhang X, Hao H, Ma L, Zhang Y, Hu X, Chen Z, Liu D, Yuan J, Hu Z, Guan W. mBio. 2021
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19 Yang J, Zhong M, Zhang E, Hong K, Yang Q, Zhou D, Xia J, Chen YQ, Sun M, Zhao B, Xiang J, Liu Y, Han Y, Xu M, Zhou X, Huang C, Shang Y, Yan H. J Mol Cell Biol. 2021
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease Su H, Yao S, Zhao W, Zhang Y, Liu J, Shao Q, Wang Q, Li M, Xie H, Shang W, Ke C, Feng L, Jiang X, Shen J, Xiao G, Jiang H, Zhang L, Ye Y, Xu Y. Nat Commun. 2021
Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial Shu YJ, He JF, Pei RJ, He P, Huang ZH, Chen SM, Ou ZQ, Deng JL, Zeng PY, Zhou J, Min YQ, Deng F, Peng H, Zhang Z, Wang B, Xu ZH, Guan WX, Hu ZY, Zhang JK. Chin Med J (Engl). 2021
Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries Pan Y, Du J, Liu J, Wu H, Gui F, Zhang N, Deng X, Song G, Li Y, Lu J, Wu X, Zhan S, Jing Z, Wang J, Yang Y, Liu J, Chen Y, Chen Q, Zhang H, Hu H, Duan K, Wang M, Wang Q, Yang X. Cell Discov. 2021
Generation and characterization of self-assembled protein nanocages based on β-carboxysomes in Escherichia coli Gao R, Zhang XE, Li F. Acta Biochim Biophys Sin (Shanghai) 2021
Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants Qu Y, Zhang X, Wang M, Sun L, Jiang Y, Li C, Wu W, Chen Z, Yin Q, Jiang X, Liu Y, Li C, Li J, Ying T, Li D, Zhan F, Wang Y, Guan W, Wang S, Liang M. Virol Sin. 2021
Recovery of a Far-Eastern Strain of Tick-Borne Encephalitis Virus with a Full-Length Infectious cDNA Clone Li P, Yao C, Wang T, Wu T, Yi W, Zheng Y, Miao Y, Sun J, Tan Z, Liu Y, Zhang X, Wang H, Zheng Z. Virol Sin. 2021
Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies Dai S, Deng F, Wang H, Ning Y. Viruses 2021
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses Yang Y, Wang X, Du RH, Zhang W, Si HR, Zhu Y, Shen XR, Li Q, Li B, Men D, Zhou YN, Wang H, Tong XL, Zhang XE, Shi ZL, Zhou P. Emerg Microbes Infect 2021
Rapid determination of infectious SARS-CoV-2 in PCR-positive samples by SDS-PMA assisted RT-qPCR Hong W, Xiong J, Nyaruaba R, Li J, Muturi E, Liu H, Yu J, Yang H, Wei H. Sci Total Environ. 2021
Bat virome research: the past, the present and the future Tan CW, Yang X, Anderson DE, Wang LF. Curr Opin Virol. 2021
Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation Wang W, Li SS, Xu XF, Yang C, Niu XG, Yin SX, Pan XY, Xu W, Hu GD, Wang C, Liu SW. Acta Pharmacol Sin. 2021
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates Wang Y, Fang S, Wu Y, Cheng X, Zhang LK, Shen XR, Li SQ, Xu JR, Shang WJ, Gao ZB, Xia BQ. Acta Pharmacol Sin. 2021
SARS-CoV-2 NSP12 protein is not an IFN-β antagonist Li A, Zhao K, Zhang B, Hua R, Fang Y, Jiang W, Zhang J, Hui L, Zheng Y, Li Y, Zhu C, Wang PH, Peng K, Xia Y. J Virol. 2021